ReviewsAcute coronary syndromes in cancer patientsBisceglia, Irmaa; Canale, Maria Laurab; Lestuzzi, Chiarac; Parrini, Irisd; Russo, Giuliae; Colivicchi, Furiof; Gabrielli, Domenicog; Gulizia, Michele Massimoh; Iliescu, Cezar A.i; on the behalf of ANMCO Cardio-Oncology Task ForceAuthor Information aServizi Cardiologici Integrati Cardiology Department, Azienda Ospedaliera San Camillo-Forlanini, Roma bDivision of Cardiology, Azienda USL Toscana Nord Ovest, Versilia Hospital, Lido di Camaiore cCardiology Unit, Oncology Department, CRO National Cancer Institute, Aviano dDivisione di Cardiologia, Ospedale Mauriziano, Torino eSC Centro Cardiovascolare Ospedale Maggiore, Cardiology Department, Trieste fDivision of Cardiology, San Filippo Neri Hospital, ASL Roma 1, Rome gDivision of Cardiology, Augusto Murri Hospital, Fermo hDivision of Cardiology, Garibaldi-Nesima Hospital, Catania, Italy iDepartment of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA Correspondence to Maria Laura Canale, MD, PhD, Cardiology Department, Versilia Hospital, Via Aurelia 335, Lido di Camaiore 55043, LU, Italy Tel: +39 05846059721; fax: +39 05846059719; e-mail: [email protected] Received 11 February, 2019 Revised 29 December, 2019 Accepted 25 January, 2020 Journal of Cardiovascular Medicine: December 2020 - Volume 21 - Issue 12 - p 944-952 doi: 10.2459/JCM.0000000000000993 Buy Metrics Abstract Cardiovascular disease and cancer are responsible for the majority of deaths in the Western world. These two entities share common risk factors and their intersection will be more and more frequent in future due to general population aging and long-term cancer control. Clinical presentation, management and outcome of acute coronary syndromes (ACS) in cancer patients could differ from noncancer ones. Cancer patients were frequently excluded from clinical trials and so the paucity of data further complicates the scenario. The management of ACS in cancer patients represents a unique setting in which the risk/benefit ratio of invasive treatment should be carefully evaluated. This review focused on the available evidence of all aspects of ACS in cancer patients providing a guide to a multidisciplinary approach. © 2020 Italian Federation of Cardiology - I.F.C. All rights reserved.